Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang, Aida Rashidi, Junfei Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy
Shuai Guo, Wei Xiong, Jiaoyang Zhu, et al.
Biomaterials (2023) Vol. 302, pp. 122300-122300
Closed Access | Times Cited: 45
The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 36
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 29
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Corey Dussold, Kaylee Zilinger, Jillyn Turunen, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 16
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
Justin Low, Michael C. Brown, Zachary J. Reitman, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 16
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Multifunctional nanoparticles and collagenase dual loaded thermosensitive hydrogel system for enhanced tumor-penetration, reversed immune suppression and photodynamic-immunotherapy
Chengli Yang, Xukun Liao, Kai Zhou, et al.
Bioactive Materials (2025) Vol. 48, pp. 1-17
Closed Access | Times Cited: 1
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
Wenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113224-113224
Open Access | Times Cited: 25
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
Aida Rashidi, Leah K. Billingham, Andrew Zolp, et al.
Cell Metabolism (2023) Vol. 36, Iss. 1, pp. 62-77.e8
Closed Access | Times Cited: 25
Deciphering the role of CD47 in cancer immunotherapy
Yue Liu, Linjun Weng, Yanjin Wang, et al.
Journal of Advanced Research (2023) Vol. 63, pp. 129-158
Open Access | Times Cited: 22
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 22
Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer
Chen Jian, Tingting Wu, Lulu Wang, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 14
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Small (2025)
Closed Access | Times Cited: 1
Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer Immunotherapy
Yueqiang Zhu, Liangjie Jin, Junbin Chen, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Open Access | Times Cited: 20
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiujun Qiu, Xinyi Ding, Jixiang Chen, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 681-705
Closed Access | Times Cited: 18
Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy
Jia Tan, Meifang Wang, Binbin Ding, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215316-215316
Closed Access | Times Cited: 17
Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top